← Back to companies
Ochre Bio
0 open
Oxford, Oxfordshire, United KingdomFounded 201967+ employeesSeries A raisedSeries APrivate
Last round: series a · $30M · Oct 2022(4 rounds total)
Founded by Jack O'Meara, Quin Wills
Backed by(21 investors)
Khosla VenturesR. Martin ChavezSelvedge VentureBACKED VCLifeLink VenturesKristen FortneyHermes-EpitekChristopher GibsonAixTheraAlice ZhangY CombinatorAcequia Capital (AceCap)Apollo Health Ventures
Ochre Bio is a biotechnology company developing RNA therapies for chronic liver diseases. Using a combination of genomic deep phenotyping, precision RNA medicine, and testing in live human donor livers, Ochre is developing therapies for important liver health challenges, from increasing donor liver supply to reducing cirrhosis complications. To learn more, please visit www.ochre-bio.com.
Open Positions at Ochre Bio (0 Jobs)
No open positions at the moment.
Browse All JobsReady to start your space career at Ochre Bio?
